A citation-based method for searching scientific literature

Deborah Cragun, Anne Weidner, Courtney Lewis, Devon Bonner, Jongphil Kim, Susan T Vadaparampil, Tuya Pal. Cancer 2017
Times Cited: 76



Anne Marie McCarthy, Mirar Bristol, Susan M Domchek, Peter W Groeneveld, Younji Kim, U Nkiru Motanya, Judy A Shea, Katrina Armstrong. J Clin Oncol 2016
Times Cited: 72




List of shared articles



Times cited

Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.
Anita Y Kinney, Rachel Howell, Rachel Ruckman, Jean A McDougall, Tawny W Boyce, Belinda Vicuña, Ji-Hyun Lee, Dolores D Guest, Randi Rycroft, Patricia A Valverde,[...]. Contemp Clin Trials 2018
1

Reducing Disparities in Receipt of Genetic Counseling for Underserved Women at Risk of Hereditary Breast and Ovarian Cancer.
Arnethea L Sutton, Alejandra Hurtado-de-Mendoza, John Quillin, Lisa Rubinsak, Sarah M Temkin, Tamas Gal, Vanessa B Sheppard. J Womens Health (Larchmt) 2020
0

Blending Insights from Implementation Science and the Social Sciences to Mitigate Inequities in Screening for Hereditary Cancer Syndromes.
Laura Senier, Colleen M McBride, Alex T Ramsey, Vence L Bonham, David A Chambers. Int J Environ Res Public Health 2019
0

An Overview of PARP Inhibitors for the Treatment of Breast Cancer.
Laura Cortesi, Hope S Rugo, Christian Jackisch. Target Oncol 2021
1

Uptake of BRCA 1/2 and oncotype DX testing by medical and surgical oncologists.
Yonina R Murciano-Goroff, Anne Marie McCarthy, Mirar N Bristol, Peter Groeneveld, Susan M Domchek, U Nkiru Motanya, Katrina Armstrong. Breast Cancer Res Treat 2018
4

Lack Of Diversity In Genomic Databases Is A Barrier To Translating Precision Medicine Research Into Practice.
Latrice G Landry, Nadya Ali, David R Williams, Heidi L Rehm, Vence L Bonham. Health Aff (Millwood) 2018
61

Strategies to enhance identification of hereditary breast cancer gene carriers.
Sonya Reid, Lucy B Spalluto, Tuya Pal. Expert Rev Mol Diagn 2020
0

Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations.
Kathleen F Mittendorf, Tia L Kauffman, Laura M Amendola, Katherine P Anderson, Barbara B Biesecker, Michael O Dorschner, Devan M Duenas, Donna J Eubanks, Heather Spencer Feigelson, Marian J Gilmore,[...]. Contemp Clin Trials 2021
0

Disparities in genetic services utilization in a random sample of young breast cancer survivors.
Christos Nikolaidis, Debra Duquette, Kari E Mendelsohn-Victor, Beth Anderson, Glenn Copeland, Kara J Milliron, Sofia D Merajver, Nancy K Janz, Laurel L Northouse, Sonia A Duffy,[...]. Genet Med 2019
7

Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework.
Ridgely Fisk Green, Mary Ari, Katherine Kolor, W David Dotson, Scott Bowen, Nancy Habarta, Juan L Rodriguez, Lisa C Richardson, Muin J Khoury. Genet Med 2019
16

Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United States.
Susan M Domchek, Song Yao, Fei Chen, Chunling Hu, Steven N Hart, David E Goldgar, Katherine L Nathanson, Christine B Ambrosone, Christopher A Haiman, Fergus J Couch,[...]. JAMA Oncol 2021
0

The role of genomics in global cancer prevention.
Ophira Ginsburg, Patricia Ashton-Prolla, Anna Cantor, Daniela Mariosa, Paul Brennan. Nat Rev Clin Oncol 2021
3

Precision medicine testing in ovarian cancer: The growing inequity between patients with commercial vs medicaid insurance.
Charlotte R Gamble, Yongmei Huang, Jason D Wright, June Y Hou. Gynecol Oncol 2021
0

Genetic Counseling and Testing in a Community Setting: Quality, Access, and Efficiency.
Stephanie A Cohen, Angela Bradbury, Vida Henderson, Kent Hoskins, Erica Bednar, Banu K Arun. Am Soc Clin Oncol Educ Book 2019
16

Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population.
Kathleen F Mittendorf, Chinedu Ukaegbu, Marian J Gilmore, Nangel M Lindberg, Tia L Kauffman, Donna J Eubanks, Elizabeth Shuster, Jake Allen, Carmit McMullen, Heather Spencer Feigelson,[...]. Fam Cancer 2021
0


BRCA1/2 Testing in Massachusetts Among Women With Private Insurance or Medicaid, 2011-2015.
Lydia E Pace, Christopher F Baum, Krisztina Horvath, Sahitya C Raja, Jessica Cohen, Summer S Hawkins. Med Care 2020
0

Development of a culturally sensitive narrative intervention to promote genetic counseling among African American women at risk for hereditary breast cancer.
Vida Henderson, Ifeanyi Beverly Chukwudozie, DeLawnia Comer-Hagans, Vickii Coffey, Giesela Grumbach, Shirley Spencer, Carolyn Rodgers, Ravneet Kaur, Jennifer Newsome, Lara Balay,[...]. Cancer 2021
0

Considerations in Testing for Inherited Breast Cancer Predisposition in the Era of Personalized Medicine.
Benjamin Powers, Tuya Pal, Christine Laronga. Surg Oncol Clin N Am 2018
3

Disparities in Genetic Testing and Care among Black women with Hereditary Breast Cancer.
Sonya Reid, Sydney Cadiz, Tuya Pal. Curr Breast Cancer Rep 2020
0

Proposed outcomes measures for state public health genomic programs.
Debra Lochner Doyle, Mindy Clyne, Juan L Rodriguez, Deborah L Cragun, Laura Senier, Georgia Hurst, Kee Chan, David A Chambers. Genet Med 2018
6

Latinas' knowledge of and experiences with genetic cancer risk assessment: Barriers and facilitators.
Sara Gómez-Trillos, Vanessa B Sheppard, Kristi D Graves, Minna Song, Lyndsay Anderson, Nancy Ostrove, Katherine Lopez, Claudia Campos, Nathaly Gonzalez, Alejandra Hurtado-de-Mendoza. J Genet Couns 2020
4

Black Women's Confidence in the Genetic Information Nondiscrimination Act.
Arnethea L Sutton, Alesha Henderson, Alejandra Hurtado-de-Mendoza, Erin Tanner, Mishaal Khan, John Quillin, Vanessa B Sheppard. Int J Environ Res Public Health 2019
1


A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.
Kent F Hoskins, Silvia Tejeda, Ganga Vijayasiri, Ifeanyi Beverly Chukwudozie, Mylene H Remo, Hiral A Shah, Ivy E Abraham, Lara E Balay, Tara K Maga, Ericka R Searles,[...]. Cancer 2018
5